PMID- 23571276 OWN - NLM STAT- MEDLINE DCOM- 20130906 LR - 20211021 IS - 1559-7016 (Electronic) IS - 0271-678X (Print) IS - 0271-678X (Linking) VI - 33 IP - 7 DP - 2013 Jul TI - Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery. PG - 1104-14 LID - 10.1038/jcbfm.2013.56 [doi] AB - In cerebral ischemia, matrix metalloproteinases (MMPs) have a dual role by acutely disrupting tight junction proteins (TJPs) in the blood-brain barrier (BBB) and chronically promoting angiogenesis. Since TJP remodeling of the neurovascular unit (NVU) is important in recovery and early inhibition of MMPs is neuroprotective, we hypothesized that short-term MMP inhibition would reduce infarct size and promote angiogenesis after ischemia. Adult spontaneously hypertensive rats had a transient middle cerebral artery occlusion with reperfusion. At the onset of ischemia, they received a single dose of the MMP inhibitor, GM6001. They were studied at multiple times up to 4 weeks with immunohistochemistry, biochemistry, and magnetic resonance imaging (MRI). We observed newly formed vessels in peri-infarct regions at 3 weeks after reperfusion. Dynamic contrast-enhanced MRI showed BBB opening in new vessels. Along with the new vessels, pericytes expressed zonula occludens-1 (ZO-1) and MMP-3, astrocytes expressed ZO-1, occludin, and MMP-2, while endothelial cells expressed claudin-5. The GM6001, which reduced tissue loss at 3 to 4 weeks, significantly increased new vessel formation with expression of TJPs and MMPs. Our results show that pericytes and astrocytes act spatiotemporally, contributing to extraendothelial TJP formation, and that MMPs are involved in BBB restoration during recovery. Early MMP inhibition benefits neurovascular remodeling after stroke. FAU - Yang, Yi AU - Yang Y AD - Department of Neurology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA. FAU - Thompson, Jeffrey F AU - Thompson JF FAU - Taheri, Saeid AU - Taheri S FAU - Salayandia, Victor M AU - Salayandia VM FAU - McAvoy, Thera A AU - McAvoy TA FAU - Hill, Jeff W AU - Hill JW FAU - Yang, Yirong AU - Yang Y FAU - Estrada, Eduardo Y AU - Estrada EY FAU - Rosenberg, Gary A AU - Rosenberg GA LA - eng GR - R01 NS045847/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130410 PL - United States TA - J Cereb Blood Flow Metab JT - Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism JID - 8112566 RN - 0 (Dipeptides) RN - 0 (Matrix Metalloproteinase Inhibitors) RN - 0 (N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide) RN - 0 (Tight Junction Proteins) RN - EC 3.4.24.- (Matrix Metalloproteinases) SB - IM MH - Animals MH - Blood-Brain Barrier/drug effects/embryology/physiopathology MH - Blotting, Western MH - Brain Ischemia/*drug therapy/enzymology/pathology/physiopathology MH - Cell Death/drug effects MH - DNA Fragmentation/drug effects MH - Dipeptides/administration & dosage/*therapeutic use MH - In Situ Nick-End Labeling MH - Magnetic Resonance Imaging MH - Male MH - Matrix Metalloproteinase Inhibitors/administration & dosage/*therapeutic use MH - Matrix Metalloproteinases/*metabolism MH - Neovascularization, Physiologic/*drug effects MH - Rats MH - Rats, Inbred SHR MH - Tight Junction Proteins/*biosynthesis PMC - PMC3705440 EDAT- 2013/04/11 06:00 MHDA- 2013/09/07 06:00 PMCR- 2014/07/01 CRDT- 2013/04/11 06:00 PHST- 2012/12/03 00:00 [received] PHST- 2013/03/07 00:00 [revised] PHST- 2013/03/14 00:00 [accepted] PHST- 2013/04/11 06:00 [entrez] PHST- 2013/04/11 06:00 [pubmed] PHST- 2013/09/07 06:00 [medline] PHST- 2014/07/01 00:00 [pmc-release] AID - jcbfm201356 [pii] AID - 10.1038/jcbfm.2013.56 [doi] PST - ppublish SO - J Cereb Blood Flow Metab. 2013 Jul;33(7):1104-14. doi: 10.1038/jcbfm.2013.56. Epub 2013 Apr 10.